sfa 8:0

SFA 8:0, also known as caprylic acid or octanoic acid, is a medium‑chain saturated fatty acid composed of eight carbon atoms and a carboxylic acid functional group. It belongs to the family of saturated fatty acids (SFAs) and is classified as one of the medium‑chain fatty acids (MCFAs), distinguished by chain lengths of 6–12 carbon atoms. Caprylic acid is present naturally in several food sources, particularly tropical oils such as coconut oil and palm kernel oil, and in dairy fats from milk and cheese. In triglycerides, it is esterified primarily at the sn‑1 and sn‑3 positions, which facilitates its relatively rapid hydrolysis and absorption in the gastrointestinal tract compared with long‑chain fatty acids. The systematic chemical name for SFA 8:0 is octanoic acid, reflecting its eight‑carbon chain and carboxylic acid structure. This fatty acid appears as a colorless oily liquid in its pure form and imparts a faint odor that can be described as slightly acidic or fruity. MCFAs like caprylic acid are metabolized differently than long‑chain fats: they are absorbed directly into the portal circulation and transported to the liver for rapid oxidation and use as energy. Caprylic acid is integrated into broader nutritional and metabolic contexts because it contributes to ketogenic responses when consumed as part of medium‑chain triglycerides (MCTs), which can influence energy substrate utilization. This rapid metabolism has made caprylic acid of particular interest in both dietary and clinical research settings. The compound is also found as an industrial chemical, used in the synthesis of esters and in various manufacturing processes, but dietary intake typically arises from natural foods. Unlike essential vitamins or minerals, SFA 8:0 does not have an established recommended dietary allowance or adequate intake. Instead, dietary guidance focuses on total fat and saturated fat consumption, and authoritative bodies like the World Health Organization recommend limiting saturated fat intake due to associations with cardiovascular disease. However, individual saturated fatty acids can have distinct metabolic properties.

Caprylic acid (C8:0) functions in human physiology in ways that are distinct from long‑chain saturated fatty acids. Because of its medium chain length, C8:0 is taken up rapidly via the portal vein and transported to the liver, where it undergoes β‑oxidation for energy production. This rapid metabolism contributes to its inclusion in medium‑chain triglyceride (MCT) oils that are sometimes used to support energy balance and ketone body production. A recent systematic review and meta‑analysis examined how caprylic acid influences ketogenesis, particularly when carbohydrate intake is low, demonstrating that C8:0 significantly supports ketone production compared to combined carbohydrate and caprylic acid intake, although the ketogenic effect varies by study design and dose. Beyond energy metabolism, preclinical studies suggest molecular mechanisms by which caprylic acid may influence lipid metabolism and inflammation. For example, research in mice and macrophage models showed that C8:0 supplementation decreased total cholesterol and LDL‑C while increasing the HDL‑C/LDL‑C ratio through modulation of inflammatory pathways involving ABCA1 and the JAK2/STAT3 axis. Inflammatory cytokines such as TNF‑α and NF‑κB were also downregulated in these models, indicating a potential anti‑inflammatory effect at the cellular level. Additionally, dietary caprylic acid has been implicated in the regulation of ghrelin, the hunger hormone: dietary MCFAs can serve as substrates for the ghrelin O‑acyltransferase (GOAT) enzyme, which acylates ghrelin and is necessary for its activation. Modulation of ghrelin acylation may influence energy intake regulation, appetite, and metabolic homeostasis. Beyond metabolic processes, caprylic acid exhibits antimicrobial properties. In laboratory settings, C8:0 has demonstrated inhibitory effects against certain fungal species, such as Candida albicans, by disrupting microbial cell membranes. This antimicrobial activity has led to its use in adjunctive gut health protocols, although high‑quality clinical evidence in humans remains limited. MCT oils rich in caprylic acid are sometimes incorporated into dietary strategies intended to support gut microbial balance and overall digestive function. While caprylic acid and MCTs may have applications in supporting energy metabolism and microbial balance, clinical evidence from large, high‑quality randomized controlled trials in humans is presently sparse. Most health claims derive from mechanistic research, small intervention studies, or animal models, and general dietary recommendations emphasize balanced fat intake within overall dietary patterns rather than supplementation with isolated fatty acids.

Unlike vitamins and minerals, individual fatty acids such as caprylic acid do not have specific recommended dietary intakes set by authoritative bodies like the National Institutes of Health or the Food and Nutrition Board. There is no Recommended Dietary Allowance (RDA), Adequate Intake (AI), or Tolerable Upper Intake Level (UL) established exclusively for SFA 8:0. Daily Values on nutrition labels cover total fat and saturated fat rather than individual fatty acid species, and current dietary guidance focuses on limiting overall saturated fat intake to reduce cardiovascular disease risk. For example, the World Health Organization’s guideline on saturated fatty acid intake recommends that saturated fats constitute less than a certain percentage of total caloric intake to mitigate heart disease risk. Because caprylic acid is a component of total saturated fats in foods like coconut oil, palm kernel oil, dairy, and others, its contribution is considered in the context of overall saturated fat consumption rather than isolated requirements. Individuals consuming diets high in MCTs or ketogenic diets may intentionally incorporate more caprylic acid through medium‑chain triglyceride supplements. In those settings, daily caprylic acid intake may range from a few grams per day up to roughly 11–19 g or more, depending on the dietary protocol. A recent systematic review of C8:0‑induced ketogenesis found that different intervention groups consumed varying caprylic acid doses to assess effects on ketone production. However, these doses are not official intake recommendations but rather research parameters. Factors influencing needs include overall energy requirements, metabolic health status, dietary patterns, and specific clinical contexts such as ketogenic diet therapy for drug‑resistant epilepsy, where MCTs are used under medical supervision. People with certain metabolic conditions, such as medium‑chain acyl‑CoA dehydrogenase (MCAD) deficiency, should avoid high doses of caprylic acid due to impaired β‑oxidation. The absence of a defined RDA underscores the importance of integrating caprylic acid within broader fat consumption guidelines rather than focusing on precise intake targets. Individuals should consult qualified healthcare professionals when considering high doses of medium‑chain fatty acids for therapeutic purposes.

Because caprylic acid is not classified as an essential nutrient with a definitive intake requirement, there are no specific deficiency syndromes attributed solely to inadequate SFA 8:0 consumption. Unlike vitamins or minerals whose lack leads to characteristic clinical diseases, insufficient intake of an individual fatty acid like caprylic acid does not produce a defined deficiency disease. The human body can synthesize many fatty acids endogenously to meet structural and metabolic needs, though essential fatty acids with specific roles (e.g., linoleic and alpha‑linolenic acid) are required from the diet. Caprylic acid is one of several saturated fatty acids present in dietary fats and contributes to total saturated fat intake without being individually essential. Nonetheless, because it participates in physiological processes like ghrelin acylation and rapid energy metabolism, very low intake of medium‑chain triglycerides could theoretically alter these transient metabolic patterns, though such effects are not recognized as deficiency symptoms. Clinical symptoms specifically linked to low dietary caprylic acid are not documented in scientific literature, and routine blood tests do not measure SFA 8:0 levels as markers of nutritional status. People with extremely low total fat intake might experience broader issues related to insufficient energy or fatty acid metabolism, but these outcomes are not specific to caprylic acid. Instead, public health guidance centers on balanced consumption of total fats, including saturated, monounsaturated, and polyunsaturated fats. Because of its metabolism and roles within ketogenic and MCT diets, individuals engaging in such dietary frameworks may notice changes in energy patterns, ketone production, or appetite regulation when modifying caprylic acid intake—but these are functional metabolic responses rather than deficiency manifestations. Healthcare providers may monitor overall fat status, liver function, and metabolic parameters in special clinical contexts rather than assess individual MCFA levels. Consequently, the concept of a clinical deficiency for SFA 8:0 does not apply in conventional nutritional medicine.

Caprylic acid appears naturally in various foods, particularly those rich in medium‑chain triglycerides. Tropical oils like coconut oil contain the highest concentrations: coconut oil provides about 6.8 g of caprylic acid per 100 g of oil, and babassu oil supplies around 6 g per 100 g. Dried coconut meat and fresh coconut meat also contain significant amounts, with dried coconut providing over 4 g per 100 g. Coconut milk and cream are additional sources, contributing caprylic acid as part of their fat fraction. Dairy products contain lower but notable levels of caprylic acid within their saturated fat profiles; goat cheese, feta, Gruyere, and other cheeses contain measurable amounts as part of their total fat. Even whole milk and butter contribute small quantities. Because many food composition databases do not disaggregate individual fatty acids on labels, precise values for caprylic acid often require specialized nutrient datasets. Nonetheless, nutrition data ranking tools list a wide variety of foods with measurable SFA 8:0 content, ranging from coconut‑based ingredients to certain cheeses and even processed foods like coconut bars or milk chocolate with coconut and other fats. When incorporating foods rich in caprylic acid into the diet, it’s important to consider the broader nutritional context. Coconut oil and similar tropical fats are high in total saturated fat, and major health authorities advise limiting saturated fat intake to reduce cardiovascular disease risk. Integrating these foods within a balanced nutrition pattern that includes monounsaturated and polyunsaturated fats, lean proteins, whole grains, fruits, and vegetables can help ensure dietary quality. For individuals following ketogenic or MCT‑enriched diets under medical guidance, concentrated sources of caprylic acid such as structured MCT oils or enriched foods may be incorporated to support ketosis. However, for the general population, whole food sources like coconut products and dairy can provide modest amounts of SFA 8:0 alongside other nutrients. Food preparation methods and combinations (such as using coconut milk in curries or whole milk in dishes) influence total dietary saturated fat content, so thoughtful menu planning is advisable. Always consider saturated fat recommendations and consult nutrition professionals when tailoring diets for specific health goals.

Caprylic acid’s medium chain length confers unique absorption and metabolic characteristics compared with long‑chain fatty acids. Following ingestion, medium‑chain fatty acids like C8:0 are hydrolyzed from triglycerides in the small intestine by pancreatic lipase and absorbed directly into the portal circulation rather than via chylomicrons through the lymphatic system. This direct portal transport to the liver facilitates rapid β‑oxidation for energy and ketone body production. The efficiency of this pathway underlies the inclusion of caprylic acid in medium‑chain triglyceride (MCT) oils used for ketogenic diets and energy support. Factors enhancing absorption include co‑consumption with other fats that stimulate bile release and optimal pancreatic enzyme activity. Digestive conditions that impair lipase or bile secretion can reduce the efficiency of medium‑chain fatty acid uptake. While caprylic acid itself is relatively well absorbed, the food matrix influences its bioavailability: triglycerides rich in C8:0, such as MCT oils, tend to be more rapidly absorbed than when bound within complex fats of whole foods. The presence of other nutrients like fiber can slow gastric emptying and modulate the rate of fatty acid absorption. Bioavailability is not hindered significantly by typical inhibitors of long‑chain fatty acid absorption, such as plant sterols, because medium‑chain fatty acids bypass micellar transport. Overall, C8:0’s unique absorption pathway contributes to its rapid metabolism and distinctive physiological effects.

Although foods naturally supply caprylic acid as part of dietary fats, concentrated supplements exist, often marketed within MCT oil products. Individuals may consider supplements for specific health goals under professional guidance. For example, MCT oils containing high proportions of caprylic acid are used in ketogenic diet therapy to support ketone production in drug‑resistant epilepsy, where controlled medical supervision assesses efficacy and safety. Supplements commonly provide caprylic acid in the form of C8 MCT oil or as part of structured triglycerides designed to maximize ketogenic potential. Typical supplemental doses in research protocols range from a few grams up to about 11–19 g per day, though these reflect trial parameters rather than official intake recommendations. Consumers should evaluate whether supplemental use aligns with personal health goals and consider potential effects on overall saturated fat intake. Quality considerations include third‑party testing, purity of the oil, and transparent labeling. Because high intakes of saturated fats may impact cardiovascular risk, supplements should be integrated within a balanced dietary pattern. Special populations, such as individuals with metabolic disorders or conditions like MCAD deficiency, should avoid high doses due to impaired fatty acid oxidation and potential toxicity. Pregnant or lactating women should consult healthcare providers before taking concentrated caprylic acid supplements.

There is no official tolerable upper intake level defined for caprylic acid specifically. As part of total saturated fat, authorities like the World Health Organization provide guidance on limiting saturated fat to reduce cardiovascular disease risk. High supplemental intake of caprylic acid or MCT oils may cause gastrointestinal side effects including nausea, diarrhea, and abdominal discomfort. Individuals with MCAD deficiency should avoid high doses because of impaired metabolism leading to elevated blood caprylic acid and potential serious outcomes.

Caprylic acid supplements may interact with medications including antihypertensive drugs, potentially causing additive blood pressure‑lowering effects, and NSAIDs and warfarin by displacing them from albumin and increasing active drug levels. People on such medications should discuss use with healthcare professionals.

Common Forms: MCT oil (C8), structured triglycerides

Typical Doses: 3–19 g/day in research settings

When to Take: With meals to reduce GI discomfort

Best Form: MCT oil with high C8 proportion

⚠️ Interactions: Antihypertensives, NSAIDs, Warfarin